APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lysosomal Alpha Glucosidase

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lysosomal Alpha Glucosidase Market Analysis and Forecast 2026-2032

19 December 2025191 pages

Choose your research edition.

Industry ResearchLysosomal Alpha Glucosidase Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Lysosomal Alpha Glucosidase Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Lysosomal Alpha Glucosidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lysosomal Alpha Glucosidase Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lysosomal Alpha Glucosidase Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Lysosomal Alpha Glucosidase market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lysosomal Alpha Glucosidase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lysosomal Alpha Glucosidase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lysosomal Alpha Glucosidase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lysosomal Alpha Glucosidase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lysosomal Alpha Glucosidase include Sarepta Therapeutics Inc, Pharming Group NV, Oxyrane Belgium NV, JCR Pharmaceuticals Co Ltd, Huons Co Ltd, greenovation Biotech GmbH, Genzyme Corp, Etubics Corp and Audentes Therapeutics Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lysosomal Alpha Glucosidase, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lysosomal Alpha Glucosidase, also provides the sales of main regions and countries. Of the upcoming market potential for Lysosomal Alpha Glucosidase, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lysosomal Alpha Glucosidase sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lysosomal Alpha Glucosidase market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lysosomal Alpha Glucosidase sales, projected growth trends, production technology, application and end-user industry.

Lysosomal Alpha Glucosidase Segment by Company

Sarepta Therapeutics Inc

Pharming Group NV

Oxyrane Belgium NV

JCR Pharmaceuticals Co Ltd

Huons Co Ltd

greenovation Biotech GmbH

Genzyme Corp

Etubics Corp

Audentes Therapeutics Inc

Amicus Therapeutics Inc

Lysosomal Alpha Glucosidase Segment by Type

AT-982

ATB-200

AVRRD-03

JR-162

MOSS-GAA

OXY-2810

Others

Lysosomal Alpha Glucosidase Segment by Application

Glycogen Storage Disease

Pompe Disease

Others

Lysosomal Alpha Glucosidase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lysosomal Alpha Glucosidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lysosomal Alpha Glucosidase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lysosomal Alpha Glucosidase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lysosomal Alpha Glucosidase in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lysosomal Alpha Glucosidase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lysosomal Alpha Glucosidase sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lysosomal Alpha Glucosidase Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. AT-982 Major Manufacturers Table 3. ATB-200 Major Manufacturers Table 4. AVRRD-03 Major Manufacturers Table 5. JR-162 Major Manufacturers Table 6. MOSS-GAA Major Manufacturers Table 7. OXY-2810 Major Manufacturers Table 8. Others Major Manufacturers Table 9. Global Lysosomal Alpha Glucosidase Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Glycogen Storage Disease Major Manufacturers Table 11. Pompe Disease Major Manufacturers Table 12. Others Major Manufacturers Table 13. Lysosomal Alpha Glucosidase Industry Trends Table 14. Lysosomal Alpha Glucosidase Industry Drivers Table 15. Lysosomal Alpha Glucosidase Industry Opportunities and Challenges Table 16. Lysosomal Alpha Glucosidase Industry Restraints Table 17. Global Lysosomal Alpha Glucosidase Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Lysosomal Alpha Glucosidase Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Lysosomal Alpha Glucosidase Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region (2021-2026) Table 21. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region (2027-2032) Table 22. Global Lysosomal Alpha Glucosidase Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Lysosomal Alpha Glucosidase Sales by Region (2021-2026) & (K Units) Table 24. Global Lysosomal Alpha Glucosidase Sales by Region (2027-2032) & (K Units) Table 25. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2021-2026) Table 26. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2027-2032) Table 27. Global Lysosomal Alpha Glucosidase Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Lysosomal Alpha Glucosidase Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Lysosomal Alpha Glucosidase Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Lysosomal Alpha Glucosidase Sales Market Share by Manufacturers (2021-2026) Table 31. Global Lysosomal Alpha Glucosidase Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Lysosomal Alpha Glucosidase Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Lysosomal Alpha Glucosidase Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Lysosomal Alpha Glucosidase Manufacturers, Product Type & Application Table 35. Global Lysosomal Alpha Glucosidase Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Lysosomal Alpha Glucosidase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Lysosomal Alpha Glucosidase Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Lysosomal Alpha Glucosidase Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Lysosomal Alpha Glucosidase Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2021-2026) Table 42. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2027-2032) Table 43. Global Lysosomal Alpha Glucosidase Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Lysosomal Alpha Glucosidase Sales by Type (2021-2026) & (K Units) Table 45. Global Lysosomal Alpha Glucosidase Sales by Type (2027-2032) & (K Units) Table 46. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2021-2026) Table 47. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2027-2032) Table 48. Global Lysosomal Alpha Glucosidase Price by Type (2021-2026) & (US$/Unit) Table 49. Global Lysosomal Alpha Glucosidase Price by Type (2027-2032) & (US$/Unit) Table 50. Global Lysosomal Alpha Glucosidase Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Lysosomal Alpha Glucosidase Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Lysosomal Alpha Glucosidase Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2021-2026) Table 54. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2027-2032) Table 55. Global Lysosomal Alpha Glucosidase Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Lysosomal Alpha Glucosidase Sales by Application (2021-2026) & (K Units) Table 57. Global Lysosomal Alpha Glucosidase Sales by Application (2027-2032) & (K Units) Table 58. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2021-2026) Table 59. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2027-2032) Table 60. Global Lysosomal Alpha Glucosidase Price by Application (2021-2026) & (US$/Unit) Table 61. Global Lysosomal Alpha Glucosidase Price by Application (2027-2032) & (US$/Unit) Table 62. Sarepta Therapeutics Inc Company Information Table 63. Sarepta Therapeutics Inc Business Overview Table 64. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio Table 66. Sarepta Therapeutics Inc Recent Development Table 67. Pharming Group NV Company Information Table 68. Pharming Group NV Business Overview Table 69. Pharming Group NV Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Pharming Group NV Lysosomal Alpha Glucosidase Product Portfolio Table 71. Pharming Group NV Recent Development Table 72. Oxyrane Belgium NV Company Information Table 73. Oxyrane Belgium NV Business Overview Table 74. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Portfolio Table 76. Oxyrane Belgium NV Recent Development Table 77. JCR Pharmaceuticals Co Ltd Company Information Table 78. JCR Pharmaceuticals Co Ltd Business Overview Table 79. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Portfolio Table 81. JCR Pharmaceuticals Co Ltd Recent Development Table 82. Huons Co Ltd Company Information Table 83. Huons Co Ltd Business Overview Table 84. Huons Co Ltd Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Huons Co Ltd Lysosomal Alpha Glucosidase Product Portfolio Table 86. Huons Co Ltd Recent Development Table 87. greenovation Biotech GmbH Company Information Table 88. greenovation Biotech GmbH Business Overview Table 89. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Portfolio Table 91. greenovation Biotech GmbH Recent Development Table 92. Genzyme Corp Company Information Table 93. Genzyme Corp Business Overview Table 94. Genzyme Corp Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Genzyme Corp Lysosomal Alpha Glucosidase Product Portfolio Table 96. Genzyme Corp Recent Development Table 97. Etubics Corp Company Information Table 98. Etubics Corp Business Overview Table 99. Etubics Corp Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Etubics Corp Lysosomal Alpha Glucosidase Product Portfolio Table 101. Etubics Corp Recent Development Table 102. Audentes Therapeutics Inc Company Information Table 103. Audentes Therapeutics Inc Business Overview Table 104. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio Table 106. Audentes Therapeutics Inc Recent Development Table 107. Amicus Therapeutics Inc Company Information Table 108. Amicus Therapeutics Inc Business Overview Table 109. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio Table 111. Amicus Therapeutics Inc Recent Development Table 112. North America Lysosomal Alpha Glucosidase Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Lysosomal Alpha Glucosidase Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Lysosomal Alpha Glucosidase Sales by Type (2021-2026) & (K Units) Table 115. North America Lysosomal Alpha Glucosidase Sales by Type (2027-2032) & (K Units) Table 116. North America Lysosomal Alpha Glucosidase Sales Price by Type (2021-2026) & (US$/Unit) Table 117. North America Lysosomal Alpha Glucosidase Sales Price by Type (2027-2032) & (US$/Unit) Table 118. North America Lysosomal Alpha Glucosidase Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Lysosomal Alpha Glucosidase Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Lysosomal Alpha Glucosidase Sales by Application (2021-2026) & (K Units) Table 121. North America Lysosomal Alpha Glucosidase Sales by Application (2027-2032) & (K Units) Table 122. North America Lysosomal Alpha Glucosidase Sales Price by Application (2021-2026) & (US$/Unit) Table 123. North America Lysosomal Alpha Glucosidase Sales Price by Application (2027-2032) & (US$/Unit) Table 124. North America Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Lysosomal Alpha Glucosidase Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 128. North America Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 129. North America Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 130. North America Lysosomal Alpha Glucosidase Sales Price by Country (2021-2026) & (US$/Unit) Table 131. North America Lysosomal Alpha Glucosidase Sales Price by Country (2027-2032) & (US$/Unit) Table 132. United States Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 133. Canada Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 134. Europe Lysosomal Alpha Glucosidase Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Lysosomal Alpha Glucosidase Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Lysosomal Alpha Glucosidase Sales by Type (2021-2026) & (K Units) Table 137. Europe Lysosomal Alpha Glucosidase Sales by Type (2027-2032) & (K Units) Table 138. Europe Lysosomal Alpha Glucosidase Sales Price by Type (2021-2026) & (US$/Unit) Table 139. Europe Lysosomal Alpha Glucosidase Sales Price by Type (2027-2032) & (US$/Unit) Table 140. Europe Lysosomal Alpha Glucosidase Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Lysosomal Alpha Glucosidase Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Lysosomal Alpha Glucosidase Sales by Application (2021-2026) & (K Units) Table 143. Europe Lysosomal Alpha Glucosidase Sales by Application (2027-2032) & (K Units) Table 144. Europe Lysosomal Alpha Glucosidase Sales Price by Application (2021-2026) & (US$/Unit) Table 145. Europe Lysosomal Alpha Glucosidase Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Europe Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Europe Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Europe Lysosomal Alpha Glucosidase Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 150. Europe Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 151. Europe Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 152. Europe Lysosomal Alpha Glucosidase Sales Price by Country (2021-2026) & (US$/Unit) Table 153. Europe Lysosomal Alpha Glucosidase Sales Price by Country (2027-2032) & (US$/Unit) Table 154. Germany Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 155. France Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 156. U.K. Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 157. Italy Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 158. Netherlands Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 159. China Lysosomal Alpha Glucosidase Revenue by Type (2021-2026) & (US$ Million) Table 160. China Lysosomal Alpha Glucosidase Revenue by Type (2027-2032) & (US$ Million) Table 161. China Lysosomal Alpha Glucosidase Sales by Type (2021-2026) & (K Units) Table 162. China Lysosomal Alpha Glucosidase Sales by Type (2027-2032) & (K Units) Table 163. China Lysosomal Alpha Glucosidase Sales Price by Type (2021-2026) & (US$/Unit) Table 164. China Lysosomal Alpha Glucosidase Sales Price by Type (2027-2032) & (US$/Unit) Table 165. China Lysosomal Alpha Glucosidase Revenue by Application (2021-2026) & (US$ Million) Table 166. China Lysosomal Alpha Glucosidase Revenue by Application (2027-2032) & (US$ Million) Table 167. China Lysosomal Alpha Glucosidase Sales by Application (2021-2026) & (K Units) Table 168. China Lysosomal Alpha Glucosidase Sales by Application (2027-2032) & (K Units) Table 169. China Lysosomal Alpha Glucosidase Sales Price by Application (2021-2026) & (US$/Unit) Table 170. China Lysosomal Alpha Glucosidase Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Asia Lysosomal Alpha Glucosidase Revenue by Type (2021-2026) & (US$ Million) Table 172. Asia Lysosomal Alpha Glucosidase Revenue by Type (2027-2032) & (US$ Million) Table 173. Asia Lysosomal Alpha Glucosidase Sales by Type (2021-2026) & (K Units) Table 174. Asia Lysosomal Alpha Glucosidase Sales by Type (2027-2032) & (K Units) Table 175. Asia Lysosomal Alpha Glucosidase Sales Price by Type (2021-2026) & (US$/Unit) Table 176. Asia Lysosomal Alpha Glucosidase Sales Price by Type (2027-2032) & (US$/Unit) Table 177. Asia Lysosomal Alpha Glucosidase Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia Lysosomal Alpha Glucosidase Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia Lysosomal Alpha Glucosidase Sales by Application (2021-2026) & (K Units) Table 180. Asia Lysosomal Alpha Glucosidase Sales by Application (2027-2032) & (K Units) Table 181. Asia Lysosomal Alpha Glucosidase Sales Price by Application (2021-2026) & (US$/Unit) Table 182. Asia Lysosomal Alpha Glucosidase Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Asia Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Asia Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Asia Lysosomal Alpha Glucosidase Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 187. Asia Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 188. Asia Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 189. Asia Lysosomal Alpha Glucosidase Sales Price by Country (2021-2026) & (US$/Unit) Table 190. Asia Lysosomal Alpha Glucosidase Sales Price by Country (2027-2032) & (US$/Unit) Table 191. Japan Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 192. South Korea Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 193. India Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 194. Australia Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 195. China Taiwan Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 196. Southeast Asia Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 197. SAMEA Lysosomal Alpha Glucosidase Revenue by Type (2021-2026) & (US$ Million) Table 198. SAMEA Lysosomal Alpha Glucosidase Revenue by Type (2027-2032) & (US$ Million) Table 199. SAMEA Lysosomal Alpha Glucosidase Sales by Type (2021-2026) & (K Units) Table 200. SAMEA Lysosomal Alpha Glucosidase Sales by Type (2027-2032) & (K Units) Table 201. SAMEA Lysosomal Alpha Glucosidase Sales Price by Type (2021-2026) & (US$/Unit) Table 202. SAMEA Lysosomal Alpha Glucosidase Sales Price by Type (2027-2032) & (US$/Unit) Table 203. SAMEA Lysosomal Alpha Glucosidase Revenue by Application (2021-2026) & (US$ Million) Table 204. SAMEA Lysosomal Alpha Glucosidase Revenue by Application (2027-2032) & (US$ Million) Table 205. SAMEA Lysosomal Alpha Glucosidase Sales by Application (2021-2026) & (K Units) Table 206. SAMEA Lysosomal Alpha Glucosidase Sales by Application (2027-2032) & (K Units) Table 207. SAMEA Lysosomal Alpha Glucosidase Sales Price by Application (2021-2026) & (US$/Unit) Table 208. SAMEA Lysosomal Alpha Glucosidase Sales Price by Application (2027-2032) & (US$/Unit) Table 209. SAMEA Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. SAMEA Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. SAMEA Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. SAMEA Lysosomal Alpha Glucosidase Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 213. SAMEA Lysosomal Alpha Glucosidase Sales by Country (2021-2026) & (K Units) Table 214. SAMEA Lysosomal Alpha Glucosidase Sales by Country (2027-2032) & (K Units) Table 215. SAMEA Lysosomal Alpha Glucosidase Sales Price by Country (2021-2026) & (US$/Unit) Table 216. SAMEA Lysosomal Alpha Glucosidase Sales Price by Country (2027-2032) & (US$/Unit) Table 217. Brazil Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 218. Argentina Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 219. Chile Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 220. Colombia Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 221. Peru Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 222. Saudi Arabia Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 223. Israel Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 224. UAE Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 225. Turkey Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 226. Iran Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 227. Egypt Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. Lysosomal Alpha Glucosidase Distributors List Table 231. Lysosomal Alpha Glucosidase Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. Lysosomal Alpha Glucosidase Image Figure 2. Global Lysosomal Alpha Glucosidase Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lysosomal Alpha Glucosidase Market Size Share 2021 VS 2025 VS 2032 Figure 4. AT-982 Image Figure 5. ATB-200 Image Figure 6. AVRRD-03 Image Figure 7. JR-162 Image Figure 8. MOSS-GAA Image Figure 9. OXY-2810 Image Figure 10. Others Image Figure 11. Global Lysosomal Alpha Glucosidase Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Lysosomal Alpha Glucosidase Market Size Share 2021 VS 2025 VS 2032 Figure 13. Glycogen Storage Disease Image Figure 14. Pompe Disease Image Figure 15. Others Image Figure 16. Global Lysosomal Alpha Glucosidase Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Lysosomal Alpha Glucosidase Revenue (2021-2032) & (US$ Million) Figure 18. Global Lysosomal Alpha Glucosidase Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Lysosomal Alpha Glucosidase Revenue Market Share by Region (2021-2032) Figure 21. Global Lysosomal Alpha Glucosidase Sales (2021-2032) & (K Units) Figure 22. Global Lysosomal Alpha Glucosidase Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Lysosomal Alpha Glucosidase Sales YoY (2021-2032) & (K Units) Figure 25. Europe Lysosomal Alpha Glucosidase Sales YoY (2021-2032) & (K Units) Figure 26. China Lysosomal Alpha Glucosidase Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Lysosomal Alpha Glucosidase Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Lysosomal Alpha Glucosidase Sales YoY (2021-2032) & (K Units) Figure 29. Global Lysosomal Alpha Glucosidase Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Lysosomal Alpha Glucosidase Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Lysosomal Alpha Glucosidase Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2021-2032) Figure 35. Global Lysosomal Alpha Glucosidase Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Lysosomal Alpha Glucosidase Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2021-2032) Figure 38. Global Lysosomal Alpha Glucosidase Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2021-2032) Figure 41. Global Lysosomal Alpha Glucosidase Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Lysosomal Alpha Glucosidase Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2021-2032) Figure 44. North America Lysosomal Alpha Glucosidase Revenue Share by Type (2021-2032) Figure 45. North America Lysosomal Alpha Glucosidase Sales Share by Type (2021-2032) Figure 46. North America Lysosomal Alpha Glucosidase Revenue Share by Application (2021-2032) Figure 47. North America Lysosomal Alpha Glucosidase Sales Share by Application (2021-2032) Figure 48. North America Lysosomal Alpha Glucosidase Revenue Share by Country (2021-2032) Figure 49. North America Lysosomal Alpha Glucosidase Sales Share by Country (2021-2032) Figure 50. Europe Lysosomal Alpha Glucosidase Revenue Share by Type (2021-2032) Figure 51. Europe Lysosomal Alpha Glucosidase Sales Share by Type (2021-2032) Figure 52. Europe Lysosomal Alpha Glucosidase Revenue Share by Application (2021-2032) Figure 53. Europe Lysosomal Alpha Glucosidase Sales Share by Application (2021-2032) Figure 54. Europe Lysosomal Alpha Glucosidase Revenue Share by Country (2021-2032) Figure 55. Europe Lysosomal Alpha Glucosidase Sales Share by Country (2021-2032) Figure 56. China Lysosomal Alpha Glucosidase Revenue Share by Type (2021-2032) Figure 57. China Lysosomal Alpha Glucosidase Sales Share by Type (2021-2032) Figure 58. China Lysosomal Alpha Glucosidase Revenue Share by Application (2021-2032) Figure 59. China Lysosomal Alpha Glucosidase Sales Share by Application (2021-2032) Figure 60. Asia Lysosomal Alpha Glucosidase Revenue Share by Type (2021-2032) Figure 61. Asia Lysosomal Alpha Glucosidase Sales Share by Type (2021-2032) Figure 62. Asia Lysosomal Alpha Glucosidase Revenue Share by Application (2021-2032) Figure 63. Asia Lysosomal Alpha Glucosidase Sales Share by Application (2021-2032) Figure 64. Asia Lysosomal Alpha Glucosidase Revenue Share by Country (2021-2032) Figure 65. Asia Lysosomal Alpha Glucosidase Sales Share by Country (2021-2032) Figure 66. SAMEA Lysosomal Alpha Glucosidase Revenue Share by Type (2021-2032) Figure 67. SAMEA Lysosomal Alpha Glucosidase Sales Share by Type (2021-2032) Figure 68. SAMEA Lysosomal Alpha Glucosidase Revenue Share by Application (2021-2032) Figure 69. SAMEA Lysosomal Alpha Glucosidase Sales Share by Application (2021-2032) Figure 70. SAMEA Lysosomal Alpha Glucosidase Revenue Share by Country (2021-2032) Figure 71. SAMEA Lysosomal Alpha Glucosidase Sales Share by Country (2021-2032) Figure 72. Lysosomal Alpha Glucosidase Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Lysosomal Alpha Glucosidase Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • AT-982
  • ATB-200
  • AVRRD-03
  • JR-162
  • MOSS-GAA
  • OXY-2810
  • Others
Applications
  • Glycogen Storage Disease
  • Pompe Disease
  • Others
Companies covered
  • Sarepta Therapeutics Inc
  • Pharming Group NV
  • Oxyrane Belgium NV
  • JCR Pharmaceuticals Co Ltd
  • Huons Co Ltd
  • greenovation Biotech GmbH
  • Genzyme Corp
  • Etubics Corp
  • Audentes Therapeutics Inc
  • Amicus Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lysosomal Alpha Glucosidase Market by Type
  3. 1.2.1 Global Lysosomal Alpha Glucosidase Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 AT-982
  5. 1.2.3 ATB-200
  6. 1.2.4 AVRRD-03
  7. 1.2.5 JR-162
  8. 1.2.6 MOSS-GAA
  9. 1.2.7 OXY-2810
  10. 1.2.8 Others
  11. 1.3 Lysosomal Alpha Glucosidase Market by Application
  12. 1.3.1 Global Lysosomal Alpha Glucosidase Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Glycogen Storage Disease
  14. 1.3.3 Pompe Disease
  15. 1.3.4 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Lysosomal Alpha Glucosidase Market Dynamics
  1. 2.1 Lysosomal Alpha Glucosidase Industry Trends
  2. 2.2 Lysosomal Alpha Glucosidase Industry Drivers
  3. 2.3 Lysosomal Alpha Glucosidase Industry Opportunities and Challenges
  4. 2.4 Lysosomal Alpha Glucosidase Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lysosomal Alpha Glucosidase Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lysosomal Alpha Glucosidase Revenue by Region
  3. 3.2.1 Global Lysosomal Alpha Glucosidase Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lysosomal Alpha Glucosidase Revenue by Region (2021-2026)
  5. 3.2.3 Global Lysosomal Alpha Glucosidase Revenue by Region (2027-2032)
  6. 3.2.4 Global Lysosomal Alpha Glucosidase Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lysosomal Alpha Glucosidase Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lysosomal Alpha Glucosidase Sales by Region
  9. 3.4.1 Global Lysosomal Alpha Glucosidase Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lysosomal Alpha Glucosidase Sales by Region (2021-2026)
  11. 3.4.3 Global Lysosomal Alpha Glucosidase Sales by Region (2027-2032)
  12. 3.4.4 Global Lysosomal Alpha Glucosidase Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lysosomal Alpha Glucosidase Revenue by Manufacturers
  2. 4.1.1 Global Lysosomal Alpha Glucosidase Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lysosomal Alpha Glucosidase Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lysosomal Alpha Glucosidase Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lysosomal Alpha Glucosidase Sales by Manufacturers
  6. 4.2.1 Global Lysosomal Alpha Glucosidase Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lysosomal Alpha Glucosidase Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lysosomal Alpha Glucosidase Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lysosomal Alpha Glucosidase Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lysosomal Alpha Glucosidase Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lysosomal Alpha Glucosidase Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lysosomal Alpha Glucosidase Manufacturers, Product Type & Application
  13. 4.7 Global Lysosomal Alpha Glucosidase Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lysosomal Alpha Glucosidase Market CR5 and HHI
  16. 4.8.2 2025 Lysosomal Alpha Glucosidase Tier 1, Tier 2, and Tier 3
5 Lysosomal Alpha Glucosidase Market by Type
  1. 5.1 Global Lysosomal Alpha Glucosidase Revenue by Type
  2. 5.1.1 Global Lysosomal Alpha Glucosidase Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lysosomal Alpha Glucosidase Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lysosomal Alpha Glucosidase Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lysosomal Alpha Glucosidase Sales by Type
  6. 5.2.1 Global Lysosomal Alpha Glucosidase Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lysosomal Alpha Glucosidase Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Lysosomal Alpha Glucosidase Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lysosomal Alpha Glucosidase Price by Type
6 Lysosomal Alpha Glucosidase Market by Application
  1. 6.1 Global Lysosomal Alpha Glucosidase Revenue by Application
  2. 6.1.1 Global Lysosomal Alpha Glucosidase Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lysosomal Alpha Glucosidase Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lysosomal Alpha Glucosidase Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lysosomal Alpha Glucosidase Sales by Application
  6. 6.2.1 Global Lysosomal Alpha Glucosidase Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lysosomal Alpha Glucosidase Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Lysosomal Alpha Glucosidase Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lysosomal Alpha Glucosidase Price by Application
7 Company Profiles
  1. 7.1 Sarepta Therapeutics Inc
  2. 7.1.1 Sarepta Therapeutics Inc Company Information
  3. 7.1.2 Sarepta Therapeutics Inc Business Overview
  4. 7.1.3 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
  6. 7.1.5 Sarepta Therapeutics Inc Recent Developments
  7. 7.2 Pharming Group NV
  8. 7.2.1 Pharming Group NV Company Information
  9. 7.2.2 Pharming Group NV Business Overview
  10. 7.2.3 Pharming Group NV Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pharming Group NV Lysosomal Alpha Glucosidase Product Portfolio
  12. 7.2.5 Pharming Group NV Recent Developments
  13. 7.3 Oxyrane Belgium NV
  14. 7.3.1 Oxyrane Belgium NV Company Information
  15. 7.3.2 Oxyrane Belgium NV Business Overview
  16. 7.3.3 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Product Portfolio
  18. 7.3.5 Oxyrane Belgium NV Recent Developments
  19. 7.4 JCR Pharmaceuticals Co Ltd
  20. 7.4.1 JCR Pharmaceuticals Co Ltd Company Information
  21. 7.4.2 JCR Pharmaceuticals Co Ltd Business Overview
  22. 7.4.3 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Product Portfolio
  24. 7.4.5 JCR Pharmaceuticals Co Ltd Recent Developments
  25. 7.5 Huons Co Ltd
  26. 7.5.1 Huons Co Ltd Company Information
  27. 7.5.2 Huons Co Ltd Business Overview
  28. 7.5.3 Huons Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Huons Co Ltd Lysosomal Alpha Glucosidase Product Portfolio
  30. 7.5.5 Huons Co Ltd Recent Developments
  31. 7.6 greenovation Biotech GmbH
  32. 7.6.1 greenovation Biotech GmbH Company Information
  33. 7.6.2 greenovation Biotech GmbH Business Overview
  34. 7.6.3 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Product Portfolio
  36. 7.6.5 greenovation Biotech GmbH Recent Developments
  37. 7.7 Genzyme Corp
  38. 7.7.1 Genzyme Corp Company Information
  39. 7.7.2 Genzyme Corp Business Overview
  40. 7.7.3 Genzyme Corp Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Genzyme Corp Lysosomal Alpha Glucosidase Product Portfolio
  42. 7.7.5 Genzyme Corp Recent Developments
  43. 7.8 Etubics Corp
  44. 7.8.1 Etubics Corp Company Information
  45. 7.8.2 Etubics Corp Business Overview
  46. 7.8.3 Etubics Corp Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Etubics Corp Lysosomal Alpha Glucosidase Product Portfolio
  48. 7.8.5 Etubics Corp Recent Developments
  49. 7.9 Audentes Therapeutics Inc
  50. 7.9.1 Audentes Therapeutics Inc Company Information
  51. 7.9.2 Audentes Therapeutics Inc Business Overview
  52. 7.9.3 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
  54. 7.9.5 Audentes Therapeutics Inc Recent Developments
  55. 7.10 Amicus Therapeutics Inc
  56. 7.10.1 Amicus Therapeutics Inc Company Information
  57. 7.10.2 Amicus Therapeutics Inc Business Overview
  58. 7.10.3 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Product Portfolio
  60. 7.10.5 Amicus Therapeutics Inc Recent Developments
8 North America
  1. 8.1 North America Lysosomal Alpha Glucosidase Market Size by Type
  2. 8.1.1 North America Lysosomal Alpha Glucosidase Revenue by Type (2021-2032)
  3. 8.1.2 North America Lysosomal Alpha Glucosidase Sales by Type (2021-2032)
  4. 8.1.3 North America Lysosomal Alpha Glucosidase Price by Type (2021-2032)
  5. 8.2 North America Lysosomal Alpha Glucosidase Market Size by Application
  6. 8.2.1 North America Lysosomal Alpha Glucosidase Revenue by Application (2021-2032)
  7. 8.2.2 North America Lysosomal Alpha Glucosidase Sales by Application (2021-2032)
  8. 8.2.3 North America Lysosomal Alpha Glucosidase Price by Application (2021-2032)
  9. 8.3 North America Lysosomal Alpha Glucosidase Market Size by Country
  10. 8.3.1 North America Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lysosomal Alpha Glucosidase Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lysosomal Alpha Glucosidase Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Lysosomal Alpha Glucosidase Market Size by Type
  2. 9.1.1 Europe Lysosomal Alpha Glucosidase Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lysosomal Alpha Glucosidase Sales by Type (2021-2032)
  4. 9.1.3 Europe Lysosomal Alpha Glucosidase Price by Type (2021-2032)
  5. 9.2 Europe Lysosomal Alpha Glucosidase Market Size by Application
  6. 9.2.1 Europe Lysosomal Alpha Glucosidase Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lysosomal Alpha Glucosidase Sales by Application (2021-2032)
  8. 9.2.3 Europe Lysosomal Alpha Glucosidase Price by Application (2021-2032)
  9. 9.3 Europe Lysosomal Alpha Glucosidase Market Size by Country
  10. 9.3.1 Europe Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lysosomal Alpha Glucosidase Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lysosomal Alpha Glucosidase Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Lysosomal Alpha Glucosidase Market Size by Type
  2. 10.1.1 China Lysosomal Alpha Glucosidase Revenue by Type (2021-2032)
  3. 10.1.2 China Lysosomal Alpha Glucosidase Sales by Type (2021-2032)
  4. 10.1.3 China Lysosomal Alpha Glucosidase Price by Type (2021-2032)
  5. 10.2 China Lysosomal Alpha Glucosidase Market Size by Application
  6. 10.2.1 China Lysosomal Alpha Glucosidase Revenue by Application (2021-2032)
  7. 10.2.2 China Lysosomal Alpha Glucosidase Sales by Application (2021-2032)
  8. 10.2.3 China Lysosomal Alpha Glucosidase Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lysosomal Alpha Glucosidase Market Size by Type
  2. 11.1.1 Asia Lysosomal Alpha Glucosidase Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lysosomal Alpha Glucosidase Sales by Type (2021-2032)
  4. 11.1.3 Asia Lysosomal Alpha Glucosidase Price by Type (2021-2032)
  5. 11.2 Asia Lysosomal Alpha Glucosidase Market Size by Application
  6. 11.2.1 Asia Lysosomal Alpha Glucosidase Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lysosomal Alpha Glucosidase Sales by Application (2021-2032)
  8. 11.2.3 Asia Lysosomal Alpha Glucosidase Price by Application (2021-2032)
  9. 11.3 Asia Lysosomal Alpha Glucosidase Market Size by Country
  10. 11.3.1 Asia Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lysosomal Alpha Glucosidase Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lysosomal Alpha Glucosidase Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lysosomal Alpha Glucosidase Market Size by Type
  2. 12.1.1 SAMEA Lysosomal Alpha Glucosidase Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lysosomal Alpha Glucosidase Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lysosomal Alpha Glucosidase Price by Type (2021-2032)
  5. 12.2 SAMEA Lysosomal Alpha Glucosidase Market Size by Application
  6. 12.2.1 SAMEA Lysosomal Alpha Glucosidase Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lysosomal Alpha Glucosidase Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lysosomal Alpha Glucosidase Price by Application (2021-2032)
  9. 12.3 SAMEA Lysosomal Alpha Glucosidase Market Size by Country
  10. 12.3.1 SAMEA Lysosomal Alpha Glucosidase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lysosomal Alpha Glucosidase Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lysosomal Alpha Glucosidase Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lysosomal Alpha Glucosidase Value Chain Analysis
  2. 13.1.1 Lysosomal Alpha Glucosidase Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lysosomal Alpha Glucosidase Production Mode & Process
  6. 13.2 Lysosomal Alpha Glucosidase Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lysosomal Alpha Glucosidase Distributors
  9. 13.2.3 Lysosomal Alpha Glucosidase Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst